Li Ka-shing

China rushes to develop Moderna-style cancer vaccines amid a market surge.

Jardine to buy back $642 million shares; S’pore-listed stock falls 4%

CK Hutchison rules out selling ParknShop, dismissing speculation of a merger with Wellcome.

Vodafone is buying CK Hutchison's 49% stake in VodafoneThree for £4.3bn.

CK Life Sciences plans to bring cancer vaccine candidates to China. The company aims to run investigator-initiated trials within the next year.

Li Ka-shing's ports on the Panama Canal have drawn criticism from Donald Trump, placing him between China and America

CK Hutchison's forced exit from Panama ports in February 2026 reduced overall throughput by one percent to 43.6 million TEUs, though port earnings still grew four percent to HK$9.03 billion amid broader operational gains.

Li Ka-shing's CK Asset sells a Mid-Levels penthouse for US$46.2 million, setting a 2026 record.

Li Ka-shing's charity will subsidize liver cancer surgery for 200 patients, reducing costs to HK$50,000.

Greene King is selling 150 pubs due to unprecedented costs and changing consumer behavior.

Singapore Prime Minister Lawrence Wong met Hong Kong leaders. He aims for closer cooperation between the two financial centers.

Li Ka Shing Foundation and Disney gift 24,000 domestic helpers tickets to Toy Story 5.

Superdrug's owner considers a London float as part of a $30bn dual listing later this year.

Li Ka-Shing's family is reshaping their empire by cashing out after a major stake sale.

Hong Kong's competition watchdog monitors a potential merger between Wellcome and ParknShop, the city's top two supermarket chains.

Panama raids CK Hutchison subsidiary office, seizing documents, after taking over canal ports against the company's will